Our News on Newswise

Houston Methodist Researchers Shed Light on Increased Rates of Severe Human Infections Caused by Streptococcus Subspecies

A concerning increase in global rates of severe invasive infections becoming resistant to key antibiotics has a team of infectious disease researchers at the Houston Methodist Research Institute studying a recently emerged strain of bacteria called...
1-Nov-2024 4:00 PM EDT Add to Favorites

Houston Methodist Part of National Consortium to Develop Vaccine Against Herpesviruses

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government’s Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and...
3-Oct-2024 7:05 PM EDT Add to Favorites

New Addition to Standard-of-Care Treatments for Non-Small-Cell Lung Cancer Patients Has Potential to Increase Progression-Free Survival

Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common...
3-Oct-2024 7:05 PM EDT Add to Favorites

Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium

The question isn’t if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families.
3-Oct-2024 7:05 PM EDT Add to Favorites

Newswise: gutmicrobiomeslide-web-size.ashx?mw=1382&hash=7D2FD08137CF7FCFD8BD3433DC214D3D

Houston Methodist and Rice University team up to track gut-brain connection

For the next two years, 120 Division I Rice University athletes will be part of a concussion study with Houston Methodist researchers to identify reliable and novel concussion biomarkers in their gut microbiomes in ways that standard brain imaging...
18-Sep-2024 4:05 PM EDT Add to Favorites

Newswise: 6671d32ac1e60_Amar2002.jpg

Neurology ‘house calls’ to improve quality of care and life for ALS patients

When second-year neurology resident Dr. Keelie Denson asked her ALS (Amyotrophic Lateral Sclerosis) patients what they found most lacking in ALS care, the answer was easy for Angela Amar. She and her three children, now adults, had been caring for...
18-Jun-2024 2:05 PM EDT Add to Favorites

Researchers at Houston Methodist find survival improves with open radical hysterectomy in early stage cancer

Early-stage cervical cancer patients see better survival and decreased recurrence rates after open radical hysterectomy than minimally invasive laparoscopic approaches, according to a 5-year study led by Houston Methodist researchers and published...
12-Jun-2024 1:05 PM EDT Add to Favorites

Newswise: 6631634a6d672_labeledpancreasparts.jpg

Researchers at Houston Methodist find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness

A team led by a Houston Methodist physician established a hypothesis that the microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy receptors found on each section of the pancreas, differ. This...
30-Apr-2024 5:05 PM EDT Add to Favorites


See All News

About

U.S. News & World Report has named Houston Methodist Hospital the No. 1 hospital in Texas and among the top 20 hospitals in the nation. Houston Methodist's reputation for outstanding care, treatments and research attracts patients from Texas, the nation and around the world.

Our teams of surgeons, physicians, researchers and other experts collaborate to solve medicine’s biggest challenges and turn discoveries into new therapies and treatments. Our drive for innovation is rooted in the legacy created by world-renowned cardiac surgeon Dr. Michael E. DeBakey. He performed the first coronary artery bypass surgery in Texas, and pioneered surgical advances, which have become universal practices.

These days, Houston Methodist not only is well established as a leader in heart and vascular treatments, research and education based on DeBakey’s achievements and reputation, but also is known for spearheading breakthroughs in organ transplantation, orthopedics, cancer treatment and neurology and neuroscience.

Experts

close
0.5173